PIR International

Leading global provider of Executive & Interim Search to the Life Science industry. #ExecutiveSearch #Interim #LifeSciences

[PIR International @PIR_Intl]

⏳ Participation closing this week ⏳

Our 2025/26 EU/UK Biotech C-Suite Remuneration & Diversity Study is open for participation until Friday at 6:00pm. All participants will receive free access to the full report in November 2025.

👉 Participate here: https://t.co/RK9xpFK6Xu

[PIR International @PIR_Intl]

PIR International recently partnered with @SibyllaBiotech in successfully appointing Dieter Weinand as Non-Executive Chair. Read more about our collaboration and the appointment here: https://t.co/RzlqZsXRfS

[PIR International @PIR_Intl]

We are excited to feature Rita Balice-Gordon in the latest instalment of our BioLeader interview series. Rita is the CEO of @muna_tx, a biotech company developing disease modifying therapies for neurodegenerative diseases.

👉 Read the full interview here: https://t.co/dYeyOG5XbE

[PIR International @PIR_Intl]

📊 We're pleased to announce that our 2025/26 EU/UK Biotech C-Suite Remuneration & Diversity Study, in collaboration with @Mishcon_de_Reya , is now OPEN for participation.

🔒 All entries are anonymous and confidential. Follow the link to participate: https://t.co/RK9xpFK6Xu

[PIR International @PIR_Intl]

We are pleased to announce that PIR International is partnering with the globally renowned law firm, @Mishcon_de_Reya, for the next edition of our EU/UK Biotech C-Suite Remuneration & Diversity Study.

📢 Pre-registration for participation opens soon, stay tuned.

[PIR International @PIR_Intl]

Our next BioLeaders features Bob Radie. Bob has over three decades of experience working in both public and private pharma and biotech companies. He is currently Chairman and CEO of @Neuraptive.

Follow the link to read our discussion with Bob in full. https://t.co/m4yvYlc4FP

[PIR International @PIR_Intl]

We are pleased to share some recently completed appointments and initiated searches with our clients.

Reach out to us if we can assist your business in appointing leadership and board talent in the life science space.

https://t.co/DSQX2GN3DM

[PIR International @PIR_Intl]

Congratulations to @SibyllaBiotech who recently welcomed Dieter Weinand as Chairman. It was great to support Sibylla with this crucial appointment as the company advances its technology to address challenging therapeutic targets.

Read more here: https://t.co/B0MD84gKo1

[PIR International @PIR_Intl]

Congratulations to @PhoreMostLtd on the appointment of Barbara Duncan as Chair and Stephen Dilly as NED. It was our pleasure to support PhoreMost in these significant appointments as they continue their mission to “drug the undruggable”.

Read more here: https://t.co/Kw2PhJoYl2

[PIR International @PIR_Intl]

Our Managing Partner, Sally Hope, is looking forward to attending #BioBeat25 tomorrow at the @cambridgeunion

Find out more about the event here: https://t.co/XSN3RKLgHB

[PIR International @PIR_Intl]

Our Senior Partner, Tom Bradley, is looking forward to attending the 25th #BioEquityEurope conference in Bruges 12th-14th May.

Find out more about the event here: https://t.co/RRm2R2GebH

[PIR International @PIR_Intl]

PIR International recently partnered with Monument Therapeutics in successfully appointing Robert Radie as Non-Executive Chair and Heather Preston as an Advisory Board Member. Read more about our collaboration and the appointment here: https://t.co/srTvnQAeTP

[PIR International @PIR_Intl]

Our Senior Partner, Stuart Penney, is looking forward to attending the @DANSKBIOTEK Biotech Spring Gala in Copenhagen on the 6th of May.

Find out more about the event here: https://t.co/pGaldDj3N3

[PIR International @PIR_Intl]

To mark #InternationalWomensDay, our Managing Partner, Sally Hope, shares her thoughts on the diversity findings in PIR International’s Biotech Board Remuneration & Diversity study released earlier this year, and the freshly released @BIA_UK Women in Biotech Leadership report.

[PIR International @PIR_Intl]

Our Managing Partner, Sally Hope, is looking forward to attending the special extended @BIA_UK Women in Biotech event in Cambridge tomorrow, in acknowledgement of International Women's Day this weekend.

Find out more about the event here: https://t.co/RyDmOMQOFN

[PIR International @PIR_Intl]

To kick off BioLeaders in 2025, we interviewed @ps_onlyconnect. Paul is currently President & CEO of @vTvTherapeutics, a clinical stage biopharma company focused on developing oral, small molecule drug candidates.

Read the full interview on our website. https://t.co/jxmJNqBJbY

[PIR International @PIR_Intl]

Our Managing Partner, Sally Hope, is looking forward to attending the @BIA_UK Gala Dinner in London on Thursday 🥂

Find out more about the event here 👉 https://t.co/P6YNFKS3kZ

[PIR International @PIR_Intl]

🚀 Available Now! As the 43rd J.P. Morgan Healthcare Conference kicks off today, we're excited to announce the release of PIR International's 2025 EU/UK Biotech Board Remuneration & Diversity Study Report.

Register on our website for access to the report.
https://t.co/un45744D8w

[PIR International @PIR_Intl]

To kick-start the J.P. Morgan Healthcare Conference next week, PIR International will be launching its 2025 EU/UK Biotech Board Remuneration & Diversity Study on Monday 13th January 🚀

Register on our website for access to the study upon release.

https://t.co/un45745aY4

[PIR International @PIR_Intl]

PIR International's EU/UK Biotech Board Remuneration & Diversity Study is set to release January 2025 📊

Our study delves into the key trends that shape the biotech board landscape. Visit our website to register and receive a copy in the New Year 📅 https://t.co/un45744D8w